Cargando…

PFKFB4 Is a Metabolic Driver of HCC Progression and Chemoresistance Through ROS Mitigation

Detalles Bibliográficos
Autores principales:	Olaizola, Paula, Banales, Jesus M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242301/ https://www.ncbi.nlm.nih.gov/pubmed/36963434 http://dx.doi.org/10.1016/j.jcmgh.2023.02.015

Ejemplares similares

HCC, diet and metabolic factors: Diet and HCC
por: Montella, Maurizio, et al.
Publicado: (2011)

Mir‐488 alleviates chemoresistance and glycolysis of colorectal cancer by targeting PFKFB3
por: Deng, Xiaojing, et al.
Publicado: (2020)

The metabolic role of PFKFB4 in androgen-independent growth in vitro and PFKFB4 expression in human prostate cancer tissue
por: Li, Ximing, et al.
Publicado: (2020)

Role of PFKFB3 and PFKFB4 in Cancer: Genetic Basis, Impact on Disease Development/Progression, and Potential as Therapeutic Targets
por: Kotowski, Krzysztof, et al.
Publicado: (2021)

Lignins from Agroindustrial by-Products as Natural Ingredients for Cosmetics: Chemical Structure and In Vitro Sunscreen and Cytotoxic Activities
por: Gordobil, Oihana, et al.
Publicado: (2020)

Therapeutic targeting of PFKFB3 and PFKFB4 in multiple myeloma cells under hypoxic conditions
por: Okabe, Seiichi, et al.
Publicado: (2022)

Involvement of PFKFB3 in Pulmonary Arterial Hypertension Pathogenesis. Is It All about Glycolysis?
por: Bonnet, Sebastien, et al.
Publicado: (2019)

Hepatocyte phosphatase DUSP22 mitigates NASH-HCC progression by targeting FAK
por: Ge, Chenxu, et al.
Publicado: (2022)

ZEB1 Fuels Serine Metabolism to Promote HCC Metastasis
por: Chan, For-Fan, et al.
Publicado: (2023)

PFKFB3 Regulates Chemoresistance, Metastasis and Stemness via IAP Proteins and the NF-κB Signaling Pathway in Ovarian Cancer
por: Jiang, Yu-xin, et al.
Publicado: (2022)

The influence of PFK-II overexpression on neuroblastoma patients’ survival may be dependent on the particular isoenzyme expressed, PFKFB3 or PFKFB4
por: Trojan, Sonia E., et al.
Publicado: (2019)

KIF14 and KIF23 Promote Cell Proliferation and Chemoresistance in HCC Cells, and Predict Worse Prognosis of Patients with HCC
por: Cheng, Chunxia, et al.
Publicado: (2020)

Hepatocellular carcinoma: HCC
por: Blum, Hubert E.
Publicado: (2011)

Intratumor heterogeneity in HCC
por: Friemel, Juliane, et al.
Publicado: (2015)

Tuning PFKFB3 Bisphosphatase Activity Through Allosteric Interference
por: Macut, Helena, et al.
Publicado: (2019)

Roles of PFKFB3 in cancer
por: Shi, Linlin, et al.
Publicado: (2017)

Inhibition of PFKFB3 Hampers the Progression of Atherosclerosis and Promotes Plaque Stability
por: Poels, Kikkie, et al.
Publicado: (2020)

The kinase domain of PFKFB4 is required to stimulate the glucose metabolism and growth of H460 xenografts
por: Clark, J, et al.
Publicado: (2014)

Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer
por: Dasgupta, Subhamoy, et al.
Publicado: (2018)

High expression of metabolic enzyme PFKFB4 is associated with poor prognosis of operable breast cancer
por: Yao, Ling, et al.
Publicado: (2019)

Sex differences in metabolic pathways are regulated by Pfkfb3 and Pdk4 expression in rodent muscle
por: Christianto, Antonius, et al.
Publicado: (2021)

Protein kinase C inhibitors override ZEB1-induced chemoresistance in HCC
por: Sreekumar, Rahul, et al.
Publicado: (2019)

THOC3 interacts with YBX1 to promote lung squamous cell carcinoma progression through PFKFB4 mRNA modification
por: Yu, Tao, et al.
Publicado: (2023)

Evolution of systemic therapy for advanced HCC patients: Did we make progress in 2022?
por: Wong, Jeffrey Sum Lung, et al.
Publicado: (2023)

PFKFB4 promotes lung adenocarcinoma progression via phosphorylating and activating transcriptional coactivator SRC-2
por: Meng, Jiguang, et al.
Publicado: (2021)

Molecular network of HCC aggressiveness
por: Kim, Sang Geon, et al.
Publicado: (2015)

Strategies for HCC target discovery
por: Molina-Sánchez, Pedro, et al.
Publicado: (2017)

Human Hepatocellular Carcinoma (HCC)
por: Buonaguro, Luigi
Publicado: (2020)

CD44ICD promotes breast cancer stemness via PFKFB4-mediated glucose metabolism
por: Gao, Ruifang, et al.
Publicado: (2018)

A Potential Oncogenic Role for PFKFB3 Overexpression in Gastric Cancer Progression
por: Lei, Lan, et al.
Publicado: (2021)

The NADPH oxidase NOX4 regulates redox and metabolic homeostasis preventing HCC progression
por: Peñuelas‐Haro, Irene, et al.
Publicado: (2023)

Cancer chemoresistance and BAK
por: Fox, Joanna L.
Publicado: (2015)

Connexin 32 downregulation is critical for chemoresistance in oxaliplatin-resistant HCC cells associated with EMT
por: Yang, Yan, et al.
Publicado: (2019)

Effect of PFKFB4 on the Prognosis and Immune Regulation of NSCLC and Its Mechanism
por: Zhou, Yong, et al.
Publicado: (2022)

Differential roles of highly expressed PFKFB4 in colon adenocarcinoma patients
por: Gu, Xiaojing, et al.
Publicado: (2023)

Incapacitated Capicua in Sorafenib-Resistant HCC
por: Yin, Dingzi, et al.
Publicado: (2020)

Extracellular Vesicles in Hepatobiliary Malignancies
por: Lapitz, Ainhoa, et al.
Publicado: (2018)

Apelin-13 Attenuates Lipopolysaccharide-Induced Inflammatory Responses and Acute Lung Injury by Regulating PFKFB3-Driven Glycolysis Induced by NOX4-Dependent ROS
por: Yuan, Yafei, et al.
Publicado: (2022)

Targeting the sugar metabolism of tumors with a first-in-class 6-phosphofructo-2-kinase (PFKFB4) inhibitor
por: Chesney, Jason, et al.
Publicado: (2015)

Hypoxic activation of PFKFB4 in breast tumor microenvironment shapes metabolic and cellular plasticity to accentuate metastatic competence
por: Dai, Tao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3vfdlpbhm1kkv35f0tfuht0sv0